These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 26947588)
1. Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer. Guo L; Zhang C; Zhu J; Yang Y; Lan J; Su G; Xie X Life Sci; 2016 Apr; 151():102-108. PubMed ID: 26947588 [TBL] [Abstract][Full Text] [Related]
2. Identification of cervical cancer proteins associated with treatment with paclitaxel and cisplatin in patients. Liu H; Han Y; Mi R; Zhang Y; Su G; Wang H; Zhou X; Liu X; Zhu B Int J Gynecol Cancer; 2011 Nov; 21(8):1452-7. PubMed ID: 22027750 [TBL] [Abstract][Full Text] [Related]
3. Proteomic identification of neoadjuvant chemotherapy-related proteins in bulky stage IB-IIA squamous cervical cancer. Zou S; Shen Q; Hua Y; Jiang W; Zhang W; Zhu X Reprod Sci; 2013 Nov; 20(11):1356-64. PubMed ID: 23599374 [TBL] [Abstract][Full Text] [Related]
4. Genetic variations in the PI3K/AKT pathway predict platinum-based neoadjuvant chemotherapeutic sensitivity in squamous cervical cancer. Guo L; Wu H; Zhu J; Zhang C; Ma J; Lan J; Xie X Life Sci; 2015 Dec; 143():217-24. PubMed ID: 26585822 [TBL] [Abstract][Full Text] [Related]
5. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy. Garzetti GG; Ciavattini A; Provinciali M; Di Stefano G; Lucarini G; Goteri G; Biagini G Anticancer Res; 1996; 16(5B):3229-34. PubMed ID: 8920796 [TBL] [Abstract][Full Text] [Related]
6. Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy. Xie Q; Liang J; Rao Q; Xie X; Li R; Liu Y; Zhou H; Han J; Yao T; Lin Z Ann Surg Oncol; 2016 Jan; 23(1):163-70. PubMed ID: 25916979 [TBL] [Abstract][Full Text] [Related]
7. Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Bae SM; Lee CH; Cho YL; Nam KH; Kim YW; Kim CK; Han BD; Lee YJ; Chun HJ; Ahn WS Gynecol Oncol; 2005 Oct; 99(1):26-35. PubMed ID: 16051329 [TBL] [Abstract][Full Text] [Related]
8. Heat shock protein 70 is involved in malignant behaviors and chemosensitivities to cisplatin in cervical squamous cell carcinoma cells. Yoshidomi K; Murakami A; Yakabe K; Sueoka K; Nawata S; Sugino N J Obstet Gynaecol Res; 2014 May; 40(5):1188-96. PubMed ID: 24689999 [TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells. Lee KH; Yim EK; Kim CJ; Namkoong SE; Um SJ; Park JS Gynecol Oncol; 2005 Jul; 98(1):45-53. PubMed ID: 15907983 [TBL] [Abstract][Full Text] [Related]
10. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells. Xia J; Yu X; Song X; Li G; Mao X; Zhang Y Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427 [TBL] [Abstract][Full Text] [Related]
11. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis. Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637 [TBL] [Abstract][Full Text] [Related]
12. Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma. Zhu H; Pei HP; Zeng S; Chen J; Shen LF; Zhong MZ; Yao RJ; Shen H J Proteome Res; 2009 Aug; 8(8):3969-76. PubMed ID: 19507834 [TBL] [Abstract][Full Text] [Related]
13. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones]. Yan XD; Pan LY Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965 [TBL] [Abstract][Full Text] [Related]
14. [Detection of Serum Peptides in Patients with Lung Squamous Cell Carcinoma by MALDI-TOF-MS and Analysis of Their Correlation with Chemotherapy Efficacy]. Zhao G; Xu B; Li X; Tang C; Qin H; Wang H; Yang S; Wang W; Gao H; He K; Liu X Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):318-325. PubMed ID: 28532539 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of cyclooxygenase-2 protein and its relationship to apoptosis in cervical carcinoma treated with neoadjuvant chemotherapy. Nagai N; Tian X; Mukai K; Hirata E; Kusuda T; Shiroyama Y; Shigemasa K; Ohama K Int J Mol Med; 2003 Nov; 12(5):709-14. PubMed ID: 14532998 [TBL] [Abstract][Full Text] [Related]
16. Proteomic identification of differentially-expressed proteins in squamous cervical cancer. Zhu X; Lv J; Yu L; Zhu X; Wu J; Zou S; Jiang S Gynecol Oncol; 2009 Jan; 112(1):248-56. PubMed ID: 19007971 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD. Chen Y; Ke G; Han D; Liang S; Yang G; Wu X Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997 [TBL] [Abstract][Full Text] [Related]
18. Analysis of differential protein expression by cisplatin treatment in cervical carcinoma cells. Yim EK; Lee KH; Kim CJ; Park JS Int J Gynecol Cancer; 2006; 16(2):690-7. PubMed ID: 16681749 [TBL] [Abstract][Full Text] [Related]
19. SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines. Chen X; Xiong D; Ye L; Yang H; Mei S; Wu J; Chen S; Mi R Cancer Chemother Pharmacol; 2019 Apr; 83(4):603-613. PubMed ID: 30627777 [TBL] [Abstract][Full Text] [Related]
20. Cyclin I promotes cisplatin resistance via Cdk5 activation in cervical cancer. Li R; Liu GZ; Luo SY; Chen R; Zhang JX Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4533-41. PubMed ID: 26698249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]